Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?

BACKGROUND/AIMS: Nonselective β-blockers (NSBBs), such as propranolol, reportedly exert a pleiotropic effect in liver cirrhosis. A previous report suggested that survival was higher in patients receiving adjusted doses of NSBBs than in ligation patients. This study investigated whether low-dose NSBB...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Kim, Tae Wan, Kim, Hong Joo, Chon, Chang Uk, Won, Hyun Sun, Park, Jung Ho, Park, Dong Il, Cho, Yong Kyun, Sohn, Chong Il, Jeon, Woo Kyu, Kim, Byung Ik
פורמט: Artigo
שפה:Inglês
יצא לאור: The Korean Association for the Study of the Liver 2012
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3415875/
https://ncbi.nlm.nih.gov/pubmed/22893871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2012.18.2.203
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים